Chronic heart failure and micronutrients.

[1]  P. Singal,et al.  Adriamycin-Induced Early Changes in Myocardial Antioxidant Enzymes and Their Modulation by Probucol , 2000, Circulation.

[2]  T. Wilkinson,et al.  Clinical Relevance of Thiamine Status amongst Hospitalized Elderly Patients , 2000, Gerontology.

[3]  M. Fisher,et al.  The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure , 2000, Annals of Internal Medicine.

[4]  C. Berry,et al.  Catabolism in chronic heart failure. , 2000, European heart journal.

[5]  J. Twisk,et al.  Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial , 2000, The Lancet.

[6]  S. Yusuf,et al.  Vitamin E supplementation and cardiovascular events in high-risk patients. , 2000, The New England journal of medicine.

[7]  S. Anker,et al.  Insulin resistance in chronic heart failure. , 2000, Journal of cardiovascular pharmacology.

[8]  P. J.,et al.  DIETARY ANTIOXIDANT VITAMINS AND DEATH FROM CORONARY HEART DISEASE IN POSTMENOPAUSAL WOMEN , 2000 .

[9]  J. Keaney,et al.  Treatment of hypertension with ascorbic acid , 1999, The Lancet.

[10]  Y. J. Kang.  The antioxidant function of metallothionein in the heart. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[12]  T J Cole,et al.  Micronutrients: highlights and research challenges from the 1994–5 National Diet and Nutrition Survey of people aged 65 years and over , 1999, British Journal of Nutrition.

[13]  J. Keaney,et al.  Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1999, Circulation.

[14]  R. Marfella,et al.  Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. , 1999, JAMA.

[15]  D. Burstow,et al.  Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. , 1999, Journal of the American College of Cardiology.

[16]  J. Michel,et al.  Decreased type VI adenylyl cyclase mRNA concentration and Mg(2+)-dependent adenylyl cyclase activities and unchanged type V adenylyl cyclase mRNA concentration and Mn(2+)-dependent adenylyl cyclase activities in the left ventricle of rats with myocardial infarction and longstanding heart failure. , 1999, Cardiovascular research.

[17]  N. Dudman,et al.  Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo. , 1999, Circulation research.

[18]  V. Palace,et al.  Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. , 1999, Free radical biology & medicine.

[19]  S. Anker,et al.  Loss of bone mineral in patients with cachexia due to chronic heart failure. , 1999, The American journal of cardiology.

[20]  T. Sellers,et al.  Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. , 1999, American journal of epidemiology.

[21]  R. Ferrari.  The Investigators of the Study on Propionyl-L-Carnitine in Chronic Heart Failure , 1999 .

[22]  Study on propionyl-L-carnitine in chronic heart failure. , 1999, European heart journal.

[23]  A. Zangen,et al.  Furosemide and digoxin inhibit thiamine uptake in cardiac cells. , 1998, European journal of pharmacology.

[24]  S. Giustiniani,et al.  Are failured cardiomyopathies a zinc-deficit related disease? A study on Zn and Cu in patients with chronic failured dilated and hypertrophic cardiomyopathies. , 1998, Minerva medica.

[25]  A. Díez-Pérez,et al.  Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure. , 1998, The American journal of medicine.

[26]  P. Poole‐Wilson,et al.  Successes and failures of current treatment of heart failure , 1998, The Lancet.

[27]  P. Poole‐Wilson,et al.  Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. , 1998, Journal of the American College of Cardiology.

[28]  A. Folsom,et al.  Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. , 1998, Circulation.

[29]  A. Palomäki,et al.  Ubiquinone supplementation during lovastatin treatment: effect on LDL oxidation ex vivo. , 1998, Journal of lipid research.

[30]  J. Cleland,et al.  Influence of concomitant disease on patterns of hospitalization in patients with heart failure discharged from Scottish hospitals in 1995. , 1998, European heart journal.

[31]  L. Ghiadoni,et al.  Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. , 1998, Circulation.

[32]  M. Breslow,et al.  Endotoxin-induced alteration in the expression of leptin and beta3-adrenergic receptor in adipose tissue. , 1998, The American journal of physiology.

[33]  M. Breslow,et al.  Endotoxin-induced alteration in the expression of leptin and β3-adrenergic receptor in adipose tissue. , 1998, American journal of physiology. Endocrinology and metabolism.

[34]  A. Plump.  Cardiovascular medicine at the turn of the millennium. , 1998, The New England journal of medicine.

[35]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. , 1998, Journal of the American College of Cardiology.

[36]  H. Drexler,et al.  Vitamin C improves endothelial function of conduit arteries in patients with chronic heart failure. , 1998, Circulation.

[37]  E. Arbustini,et al.  EFFECT OFL-CARNITINE ON MYOCARDIAL METABOLISM: RESULTS OF A BALANCED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY IN PATIENTS UNDERGOING OPEN HEART SURGERY , 1998 .

[38]  S. Vollset,et al.  Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. , 1998, The American journal of clinical nutrition.

[39]  S. Tyagi.  Homocysteine redox receptor and regulation of extracellular matrix components in vascular cells. , 1998, American journal of physiology. Cell physiology.

[40]  T. Yoshikawa,et al.  α‐tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells , 1998 .

[41]  S. Clément,et al.  Molecular basis of α‐tocopherol control of smooth muscle cell proliferation , 1998 .

[42]  T. Yoshikawa,et al.  alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. , 1998, BioFactors.

[43]  E. Arbustini,et al.  Effect of L-carnitine on myocardial metabolism: results of a balanced, placebo-controlled, double-blind study in patients undergoing open heart surgery. , 1998, Pharmacological research.

[44]  S. W. May,et al.  Selenium-based antihypertensives. Rationale and potential. , 1998, Drugs.

[45]  S. Vollset,et al.  Plasma homocysteine levels and mortality in patients with coronary artery disease. , 1997, The New England journal of medicine.

[46]  G. Plotnick,et al.  Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.

[47]  E. Braunwald.  Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.

[48]  R. Nath.  Copper deficiency and heart disease: molecular basis, recent advances and current concepts. , 1997, The international journal of biochemistry & cell biology.

[49]  M. Fisher,et al.  Daily energy requirements in heart failure patients. , 1997, Metabolism: clinical and experimental.

[50]  C. Mantzoros,et al.  Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans , 1997 .

[51]  S. Anker,et al.  Tumor necrosis factor and steroid metabolism in chronic heart failure: possible relation to muscle wasting. , 1997, Journal of the American College of Cardiology.

[52]  D. Mancini,et al.  Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. , 1997, The American journal of medicine.

[53]  S. Anker,et al.  Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. , 1997, Journal of the American College of Cardiology.

[54]  P. Ponikowski,et al.  Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. , 1997, Circulation.

[55]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. , 1997, Circulation.

[56]  S. Ripatti,et al.  Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction , 1997, The Lancet.

[57]  K. Swedberg,et al.  Skeletal muscle alterations in patients with chronic heart failure. , 1997, European heart journal.

[58]  A J Cowley,et al.  Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. , 1997, The American journal of cardiology.

[59]  J. Witteman,et al.  Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[60]  P. Ponikowski,et al.  Wasting as independent risk factor for mortality in chronic heart failure , 1997, The Lancet.

[61]  J. Salonen,et al.  First myocardial infarction in patients of Indian subcontinent and European origin: comparison of risk factors, management, and long term outcome , 1997, BMJ.

[62]  L. Zeng,et al.  Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. , 1997, International journal of cardiology.

[63]  C. Rice-Evans,et al.  The influence of antioxidant nutrients on platelet function in healthy volunteers. , 1997, Atherosclerosis.

[64]  C. Mantzoros,et al.  Leptin concentrations in relation to body mass index and the tumor necrosis factor-alpha system in humans. , 1997, The Journal of clinical endocrinology and metabolism.

[65]  G. de Pinieux,et al.  Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. , 2003, British journal of clinical pharmacology.

[66]  N. Goel,et al.  Oxy free radical system in heart failure and therapeutic role of oral vitamin E. , 1996, International journal of cardiology.

[67]  J. Loscalzo,et al.  alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. , 1996, Circulation.

[68]  P. Poole‐Wilson,et al.  Exercise limitation in chronic heart failure: central role of the periphery. , 1996, Journal of the American College of Cardiology.

[69]  T. Harris,et al.  Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. , 1996, The American journal of clinical nutrition.

[70]  J. Keaney,et al.  Vascular incorporation of alpha-tocopherol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation. , 1996, The Journal of clinical investigation.

[71]  H. Just,et al.  Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. , 1996, Circulation.

[72]  C. Long,et al.  Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. , 1996, Circulation research.

[73]  H. Morrison,et al.  Serum folate and risk of fatal coronary heart disease. , 1996, JAMA.

[74]  M. Fisher,et al.  Energy expenditure and symptom severity in men with heart failure. , 1996, The American journal of cardiology.

[75]  A. Folsom,et al.  Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. , 1996, The New England journal of medicine.

[76]  J. Wu,et al.  1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. , 1996, The Journal of clinical investigation.

[77]  F. Kelly,et al.  Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) , 1996, The Lancet.

[78]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[79]  W. Remme,et al.  Anti-ischaemic efficacy of L-propionylcarnitine--a promising novel metabolic approach to ischaemia? , 1996, European heart journal.

[80]  D. King,et al.  Fat malabsorption in elderly patients with cardiac cachexia. , 1996, Age and ageing.

[81]  R. Singh,et al.  Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3) , 1996, The American journal of cardiology.

[82]  R. Singh,et al.  A randomised, double-blind, placebo-controlled trial of L-carnitine in suspected acute myocardial infarction. , 1996, Postgraduate medical journal.

[83]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[84]  G. Mancini,et al.  Effects of vitamin E on endothelial function in men after myocardial infarction. , 1995, The American journal of cardiology.

[85]  C. Epstein,et al.  Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase , 1995, Nature Genetics.

[86]  David P Miller,et al.  Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. , 1995, Circulation.

[87]  C. Sylvén,et al.  Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. , 1995, Cardiovascular research.

[88]  C. Corsi,et al.  L-Propionylcarnitine Effect on Postexercise and Postischemic Hyperemia in Patients Affected by Peripheral Vascular Disease , 1995, Angiology.

[89]  S. Iliceto,et al.  Effects of L-carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L-Carnitine Ecocardiografia Digitalizzata Infarto Miocardico (CEDIM) Trial. , 1995, Journal of the American College of Cardiology.

[90]  R. Riezler,et al.  Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations , 1995, The Lancet.

[91]  C. Cooper,et al.  Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people , 1995, BMJ.

[92]  J. Selhub,et al.  Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate, and folate. , 1995, The American journal of cardiology.

[93]  M. Motro,et al.  Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. , 1995, The American journal of medicine.

[94]  K. Swedberg,et al.  Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group. , 1995, Journal of cardiac failure.

[95]  T. Carew,et al.  Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. , 1995, Circulation.

[96]  H. Blom,et al.  Lipid peroxidation and susceptibility of low‐density lipoprotein to in vitro oxidation in hyperhomocysteinaemia , 1995, European journal of clinical investigation.

[97]  R. D'Agostino,et al.  Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. , 1995, The New England journal of medicine.

[98]  E. Haug,et al.  Congestive heart failure caused by vitamin D deficiency? , 1995, Acta paediatrica.

[99]  C. Rock,et al.  Thiamin status, diuretic medications, and the management of congestive heart failure. , 1993, Journal of the American Dietetic Association.

[100]  B. Dirks,et al.  Ventricular fibrillation due to hypocalcemia after parathyroidectomy with autotransplantation of parathyroid tissue in a dialysis patient. , 1995, Nephron.

[101]  J. T. Saari,et al.  Weak antioxidant defenses make the heart a target for damage in copper-deficient rats. , 1994, Free radical biology & medicine.

[102]  M. Fisher,et al.  Increased Resting Metabolic Rate in Patients with Congestive Heart Failure , 1994, Annals of Internal Medicine.

[103]  J. Permert,et al.  Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure--effects of long-term dietary supplementation. , 1994, European heart journal.

[104]  D. Levy,et al.  The associations of levels of serum potassium and magnesium with ventricular premature complexes (the Framingham Heart Study). , 1994, The American journal of cardiology.

[105]  W. Remme,et al.  Effects of L-propionylcarnitine on ischemia-induced myocardial dysfunction in men with angina pectoris. , 1994, The American journal of cardiology.

[106]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[107]  M. de Lorgeril,et al.  THE BENEFICIAL EFFECT OF DIETARY ANTIOXIDANT SUPPLEMENTATION ON PLATELET AGGREGATION AND CYCLOSPORINE TREATMENT IN HEART TRANSPLANT RECIPIENTS , 1994, Transplantation.

[108]  M. Fisher,et al.  Protein-energy malnutrition in patients with ischemic and nonischemicdilated cardiomyopathy and congestive heart failure☆ , 1994 .

[109]  E Hultman,et al.  Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. , 1994, The American journal of physiology.

[110]  J. Roseman,et al.  Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. , 1994, The American journal of clinical nutrition.

[111]  J. Loscalzo,et al.  Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. , 1994, The Journal of clinical investigation.

[112]  R. Barbour,et al.  Ferrylmyoglobin formation induced by acute magnesium deficiency in perfused rat heart causes cardiac failure. , 1994, Biochimica et biophysica acta.

[113]  R. Glasgow,et al.  Thiamine deficiency in hospitalized elderly patients. , 1994, Gerontology.

[114]  M. Imbriaco,et al.  Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment. , 1994, Molecular aspects of medicine.

[115]  M. Fisher,et al.  Protein-energy malnutrition in patients with ischemic and nonischemic dilated cardiomyopathy and congestive heart failure. , 1994, The American journal of cardiology.

[116]  M. Passeri,et al.  Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators. , 1994, Molecular aspects of medicine.

[117]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[118]  I. Simpson,et al.  Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. , 1993, The American journal of cardiology.

[119]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[120]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland 1980-1990. , 1993, European heart journal.

[121]  A. Favier,et al.  Effect of zinc deficiency on lipid peroxidation status and infarct size in rat hearts. , 1993, International journal of cardiology.

[122]  A. Mazur,et al.  Copper deficiency increases the susceptibility of lipoproteins and tissues to peroxidation in rats. , 1993, The Journal of nutrition.

[123]  G. Kerrigan,et al.  Electrocardiographic Q-Tc prolongation associated with infusion of intravenous pamidronate disodium. , 1993, Postgraduate medical journal.

[124]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[125]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[126]  W. Martin,et al.  Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine‐xanthine oxidase free radical generating system , 1993, British journal of pharmacology.

[127]  P. Fenster,et al.  Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study. , 1993, Journal of the American College of Cardiology.

[128]  H. Ganther,et al.  Decreased ubiquinone levels in tissues of rats deficient in selenium. , 1993, Biochemical and biophysical research communications.

[129]  S. Jameson.  Statistical data support prediction of death within 6 months on low levels of coenzyme Q10 and other entities , 1993, The Clinical investigator.

[130]  F. Perticone,et al.  New data on the antiarrhythmic value of parenteral magnesium treatment: magnesium and ventricular arrhythmias. , 1992, Magnesium research.

[131]  H. Blömer,et al.  Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. , 1992, European heart journal.

[132]  P. Moretto,et al.  A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. , 1992, International journal of cardiology.

[133]  R. Lenkinski,et al.  Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure , 1992, Circulation.

[134]  J. McMurray,et al.  Plasma Endothelin in Chronic Heart Failure , 1992, Circulation.

[135]  J. Sadler,et al.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. , 1991, The Journal of clinical investigation.

[136]  M. Motro,et al.  Thiamine deficiency in patients with congestive heart failure receiving long-term furosemide therapy: a pilot study. , 1991, The American journal of medicine.

[137]  C. Stanford,et al.  Resting energy expenditure in chronic cardiac failure. , 1991, Clinical science.

[138]  D. Wood,et al.  Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene , 1991, The Lancet.

[139]  R. Barbour,et al.  Low extracellular magnesium results in cardiac failure in isolated perfused rat hearts. , 1991, Magnesium and trace elements.

[140]  M. Antonelli,et al.  Influence of acetyl-L-carnitine infusion on haemodynamic parameters and survival of circulatory-shock patients. , 1991, International journal of clinical pharmacology research.

[141]  J. Manson,et al.  Aspirin in the primary prevention of angina pectoris in a randomized trial of United States physicians. , 1990, The American journal of medicine.

[142]  C. Reggiani,et al.  Altered contractile properties of rat cardiac muscle during experimental thiamine deficiency and food deprivation. , 1990, Journal of molecular and cellular cardiology.

[143]  M. Fisher,et al.  Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. , 1990, Journal of the American College of Cardiology.

[144]  G. Lockitch,et al.  Cardiomyopathy associated with nonendemic selenium deficiency in a Caucasian adolescent. , 1990, The American journal of clinical nutrition.

[145]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[146]  J. Loscalzo,et al.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. , 1990, The Journal of clinical investigation.

[147]  S. Mondillo,et al.  [Dilated cardiomyopathy secondary to idiopathic hypoparathyroidism in adults. Description of a case]. , 1990, Recenti progressi in medicina.

[148]  L. Saccá,et al.  Acute and short-term efficacy of high doses of creatine phosphate in the treatment of cardiac failure , 1990 .

[149]  K. Folkers,et al.  Coenzyme Q10: clinical benefits with biochemical correlates suggesting a scientific breakthrough in the management of chronic heart failure. , 1990, International journal of tissue reactions.

[150]  H. Klein,et al.  Combined treatment with vitamins E and C in experimental myocardial infarction in pigs. , 1989, American heart journal.

[151]  A. Stewart,et al.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.

[152]  P A Poole-Wilson,et al.  Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. , 1989, Circulation.

[153]  L. Stevenson,et al.  Prevalence and hemodynamic correlates of malnutrition in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1989, The American journal of cardiology.

[154]  H. Gruchow,et al.  The influence of smoking on vitamin C status in adults. , 1989, American journal of public health.

[155]  William H. Rogers,et al.  Functional Status and Well-Being of Patients with Chronic Conditions , 1989 .

[156]  T. Akiyama,et al.  Hypocalcemic Torsades de Pointes. , 1989, Journal of electrocardiology.

[157]  J. K. Mcalpine,et al.  Hypomagnesaemia in Elderly Digitalised Patients , 1988, Scottish medical journal.

[158]  L. Monnier,et al.  Platelet function in type I diabetes: effects of supplementation with large doses of vitamin E. , 1988, The American journal of clinical nutrition.

[159]  R. Simpson,et al.  Involvement of vitamin D3 with cardiovascular function. II. Direct and indirect effects. , 1987, The American journal of physiology.

[160]  L. Klevay.  Dietary copper: a powerful determinant of cholesterolemia. , 1987, Medical hypotheses.

[161]  M. Norusis,et al.  Homocysteinemia due to folate deficiency. , 1987, Metabolism: clinical and experimental.

[162]  B. Beermann.  Thiazides and loop-diuretics therapeutic aspects. , 2009, Acta medica Scandinavica. Supplementum.

[163]  P. Wester,et al.  Intracellular electrolytes in cardiac failure. , 2009, Acta medica Scandinavica. Supplementum.

[164]  G. Rodgers,et al.  Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. , 1986, The Journal of clinical investigation.

[165]  C. Decarli,et al.  Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. , 1986, The American journal of cardiology.

[166]  C W Havard,et al.  Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa. , 1985, British medical journal.

[167]  M. Holick,et al.  Aging decreases the capacity of human skin to produce vitamin D3. , 1985, The Journal of clinical investigation.

[168]  P. Bouchard,et al.  Improvement of hypocalcemic cardiomyopathy by correction of serum calcium level. , 1985, American heart journal.

[169]  H. Lukaski,et al.  Increased cholesterol in plasma in a young man during experimental copper depletion. , 1984, Metabolism: clinical and experimental.

[170]  L. Klevay,et al.  Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency. , 1983, The American journal of physiology.

[171]  R. Mavis,et al.  The cooperative interaction between vitamin E and vitamin C in suppression of peroxidation of membrane phospholipids. , 1981, Biochimica et biophysica acta.

[172]  C. Kawai,et al.  Furosemide-induced thiamine deficiency. , 1980, Cardiovascular research.

[173]  J. White,et al.  The influence of vitamin E quinone on platelet structure, function, and biochemistry. , 1980, Blood.

[174]  G. Striker,et al.  Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. , 1980, Thrombosis research.

[175]  R. E. Burch,et al.  Serum levels of selenium, calcium, copper magnesium, manganese and zinc in various human diseases. , 1979, The Journal of nutrition.

[176]  J. L. Greger.  Dietary intake and nutritional status in regard to zinc of institutionalized aged. , 1977, Journal of gerontology.

[177]  M. Steier,et al.  Riboflavin deficiency in infants and children with heart disease. , 1976, American heart journal.

[178]  G. Littarru,et al.  Evidence for a deficiency of coenzyme Q10 in human heart disease. , 1970, Internationale Zeitschrift fur Vitaminforschung. International journal of vitamin research. Journal international de vitaminologie.

[179]  M. Shils.  EXPERIMENTAL PRODUCTION OF MAGNESIUM DEFICIENCY IN MAN * , 1969, Annals of the New York Academy of Sciences.

[180]  J. G. Pittman,et al.  The Pathogenesis of Cardiac Cachexia , 1964, The New England journal of medicine.

[181]  A. Katz,et al.  DISEASE OF THE HEART IN THE WORKS OF HIPPOCRATES , 1962, British heart journal.